Genetically enhanced T lymphocytes and the intensive care unit.
This article covers the current status of CAR-T cells and DLI research in the intensive care unit (ICU) patient, including the efficacy, toxicity, side effects and treatment.
PMID: 29662667 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: Cancer | Cancer & Oncology | Genetics | Hematology | Immunotherapy | Intensive Care | Stem Cell Therapy | Stem Cells | Toxicology | Transplants